Literature DB >> 15197065

X-linked high myopia associated with cone dysfunction.

Terri L Young1, Samir S Deeb, Shawn M Ronan, Andrew T Dewan, Alison B Alvear, Genaro S Scavello, Prasuna C Paluru, Marcia S Brott, Takaaki Hayashi, Ann M Holleschau, Nancy Benegas, Marianne Schwartz, Larry D Atwood, William S Oetting, Thomas Rosenberg, Arno G Motulsky, Richard A King.   

Abstract

OBJECTIVE: Bornholm eye disease (BED) consists of X-linked high myopia, high cylinder, optic nerve hypoplasia, reduced electroretinographic flicker with abnormal photopic responses, and deuteranopia. The disease maps to chromosome Xq28 and is the first designated high-grade myopia locus (MYP1). We studied a second family from Minnesota with a similar X-linked phenotype, also of Danish descent. All affected males had protanopia instead of deuteranopia.
METHODS: X chromosome genotyping, fine-point mapping, and haplotype analysis of the DNA from 22 Minnesota family individuals (8 affected males and 5 carrier females) and 6 members of the original family with BED were performed. Haplotype comparisons and mutation screening of the red-green cone pigment gene array were performed on DNA from both kindreds.
RESULTS: Significant maximum logarithm of odds scores of 3.38 and 3.11 at theta = 0.0 were obtained with polymorphic microsatellite markers DXS8106 and DXYS154, respectively, in the Minnesota family. Haplotype analysis defined an interval of 34.4 cM at chromosome Xq27.3-Xq28. Affected males had a red-green pigment hybrid gene consistent with protanopia. We genotyped Xq27-28 polymorphic markers of the family with BED, and narrowed the critical interval to 6.8 cM. The haplotypes of the affected individuals were different from those of the Minnesota pedigree. Bornholm eye disease-affected individuals showed the presence of a green-red hybrid gene consistent with deuteranopia.
CONCLUSIONS: Because of the close geographic origin of the 2 families, we expected affected individuals to have the same haplotype in the vicinity of the same mutation. Mapping studies, however, suggested independent mutations of the same gene. The red-green and green-red hybrid genes are common X-linked color vision defects, and thus are unrelated to the high myopia and other eye abnormalities in these 2 families. CLINICAL RELEVANCE: X-linked high myopia with possible cone dysfunction has been mapped to chromosome Xq28 with intervals of 34.4 and 6.8 centimorgan for 2 families of Danish origin.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15197065     DOI: 10.1001/archopht.122.6.897

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  35 in total

1.  Color vision in an elderly patient with protanopic genotype and successfully treated unilateral age-related macular degeneration.

Authors:  Takaaki Kitakawa; Takaaki Hayashi; Satoshi Tsuzuranuki; Akiko Kubo; Hiroshi Tsuneoka
Journal:  Int Ophthalmol       Date:  2011-11-11       Impact factor: 2.031

2.  Genomewide scan in Ashkenazi Jewish families demonstrates evidence of linkage of ocular refraction to a QTL on chromosome 1p36.

Authors:  Robert Wojciechowski; Chris Moy; Elise Ciner; Grace Ibay; Lauren Reider; Joan E Bailey-Wilson; Dwight Stambolian
Journal:  Hum Genet       Date:  2006-02-24       Impact factor: 4.132

3.  The effect of cone opsin mutations on retinal structure and the integrity of the photoreceptor mosaic.

Authors:  Joseph Carroll; Alfredo Dubra; Jessica C Gardner; Liliana Mizrahi-Meissonnier; Robert F Cooper; Adam M Dubis; Rick Nordgren; Mohamed Genead; Thomas B Connor; Kimberly E Stepien; Dror Sharon; David M Hunt; Eyal Banin; Alison J Hardcastle; Anthony T Moore; David R Williams; Gerald Fishman; Jay Neitz; Maureen Neitz; Michel Michaelides
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-12-05       Impact factor: 4.799

4.  Novel locus for X linked recessive high myopia maps to Xq23-q25 but outside MYP1.

Authors:  Q Zhang; X Guo; X Xiao; X Jia; S Li; J F Hejtmancik
Journal:  J Med Genet       Date:  2006-05       Impact factor: 6.318

5.  Refinement of the X-linked nonsyndromic high-grade myopia locus MYP1 on Xq28 and exclusion of 13 known positional candidate genes by direct sequencing.

Authors:  Uppala Ratnamala; Robert Lyle; Rakesh Rawal; Raminder Singh; Satti Vishnupriya; Pamini Himabindu; Vittal Rao; Somesh Aggarwal; Prasuna Paluru; Lucia Bartoloni; Terri L Young; Ariane Paoloni-Giacobino; Michael A Morris; Swapan K Nath; Stylianos E Antonarakis; Uppala Radhakrishna
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-08-29       Impact factor: 4.799

6.  Dissecting the genetics of human high myopia: a molecular biologic approach.

Authors:  Terri L Young
Journal:  Trans Am Ophthalmol Soc       Date:  2004

7.  Variations in opsin coding sequences cause x-linked cone dysfunction syndrome with myopia and dichromacy.

Authors:  Michelle McClements; Wayne I L Davies; Michel Michaelides; Terri Young; Maureen Neitz; Robert E MacLaren; Anthony T Moore; David M Hunt
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-02-15       Impact factor: 4.799

8.  X-linked cone dystrophy and colour vision deficiency arising from a missense mutation in a hybrid L/M cone opsin gene.

Authors:  Michelle McClements; Wayne I L Davies; Michel Michaelides; Joseph Carroll; Jungtae Rha; John D Mollon; Maureen Neitz; Robert E MacLaren; Anthony T Moore; David M Hunt
Journal:  Vision Res       Date:  2013-01-18       Impact factor: 1.886

9.  Evaluation of the X-linked high-grade myopia locus (MYP1) with cone dysfunction and color vision deficiencies.

Authors:  Ravikanth Metlapally; Michel Michaelides; Anuradha Bulusu; Yi-Ju Li; Marianne Schwartz; Thomas Rosenberg; David M Hunt; Anthony T Moore; Stephan Züchner; Catherine Bowes Rickman; Terri L Young
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-12-20       Impact factor: 4.799

10.  Clinical and linkage study on a consanguineous Chinese family with autosomal recessive high myopia.

Authors:  Zhikuan Yang; Xueshan Xiao; Shiqiang Li; Qingjiong Zhang
Journal:  Mol Vis       Date:  2009-02-09       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.